Iapyx Medical

Iapyx Medical was a medical device company specializing in the development and marketing of innovative products designed to improve patient safety and clinical outcomes in the acute care setting. The company was best known for its comprehensive oral care systems, such as the q2 and q4 kits, which were specifically engineered to reduce the incidence of Ventilator-Associated Pneumonia (VAP) in intensive care units. By focusing on standardized protocols for oral hygiene in intubated patients, Iapyx addressed a significant source of hospital-acquired infections. In 2007, the company was acquired by Kimberly-Clark Health Care, which integrated Iapyx's portfolio into its respiratory health business. These products continue to be marketed today under the Avanos Medical brand.